These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 18596718)

  • 41. Polymorphisms of adrenergic receptors and the risk of heart failure.
    Meisel C; Köpke K; Roots I
    N Engl J Med; 2003 Jan; 348(5):468-70; author reply 468-70. PubMed ID: 12556550
    [No Abstract]   [Full Text] [Related]  

  • 42. Adrenergic receptor polymorphisms in patients with stress (tako-tsubo) cardiomyopathy.
    Sharkey SW; Maron BJ; Nelson P; Parpart M; Maron MS; Bristow MR
    J Cardiol; 2009 Feb; 53(1):53-7. PubMed ID: 19167638
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Orthostatic blood pressure dysregulation and polymorphisms of β-adrenergic receptor genes in hypertensive patients.
    Gao Y; Lin Y; Sun K; Wang Y; Chen J; Wang H; Zhou X; Fan X; Hui R
    J Clin Hypertens (Greenwich); 2014 Mar; 16(3):207-13. PubMed ID: 24552127
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of polymorphisms in beta1-adrenoceptor and alpha-subunit of G protein on heart rate and blood pressure during exercise test. The Finnish Cardiovascular Study.
    Nieminen T; Lehtimäki T; Laiho J; Rontu R; Niemelä K; Kööbi T; Lehtinen R; Viik J; Turjanmaa V; Kähönen M
    J Appl Physiol (1985); 2006 Feb; 100(2):507-11. PubMed ID: 16210433
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Common genetic variation of beta1- and beta2-adrenergic receptor and response to four classes of antihypertensive treatment.
    Suonsyrjä T; Donner K; Hannila-Handelberg T; Fodstad H; Kontula K; Hiltunen TP
    Pharmacogenet Genomics; 2010 May; 20(5):342-5. PubMed ID: 20300048
    [TBL] [Abstract][Full Text] [Related]  

  • 46. β1-adrenoceptor gene Arg389Gly polymorphism and essential hypertension risk in general population: a meta-analysis.
    Wang H; Liu J; Liu K; Liu Y; Wang Z; Lou Y; Niu Q; Gu W; Wang L; Li M; Zhu X; Wen S
    Mol Biol Rep; 2013 Jun; 40(6):4055-63. PubMed ID: 23588958
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Functional variant in the (alpha)2B adrenoceptor gene, a positional candidate on chromosome 2, associates with hypertension.
    Von Wowern F; Bengtsson K; Lindblad U; Råstam L; Melander O
    Hypertension; 2004 Mar; 43(3):592-7. PubMed ID: 14744925
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Polymorphisms of adrenergic receptors and the risk of heart failure.
    Maitland ML; Gomberg-Maitland M
    N Engl J Med; 2003 Jan; 348(5):468-70; author reply 468-70. PubMed ID: 12557866
    [No Abstract]   [Full Text] [Related]  

  • 49. Synergistic polymorphisms of beta1- and alpha2C-adrenergic receptors and the risk of congestive heart failure.
    Small KM; Wagoner LE; Levin AM; Kardia SL; Liggett SB
    N Engl J Med; 2002 Oct; 347(15):1135-42. PubMed ID: 12374873
    [TBL] [Abstract][Full Text] [Related]  

  • 50. IRS1, TCF7L2, ADRB1, PPARG, and HHEX polymorphisms associated with atherogenic risk in Mexican population.
    Estrada-Velasco BI; Cruz M; Madrid-Marina V; Martínez-Nava GA; Gomez-Zamudio J; Burguete-García AI
    Biomed Res Int; 2013; 2013():394523. PubMed ID: 24371822
    [TBL] [Abstract][Full Text] [Related]  

  • 51. ADRB3 polymorphism rs4994 (Trp64Arg) associates significantly with bodyweight elevation and dyslipidaemias in Saudis but not rs1801253 (Arg389Gly) polymorphism in ARDB1.
    Daghestani M; Daghestani M; Daghistani M; Eldali A; Hassan ZK; Elamin MH; Warsy A
    Lipids Health Dis; 2018 Mar; 17(1):58. PubMed ID: 29587766
    [TBL] [Abstract][Full Text] [Related]  

  • 52. For the patient. Genetic science working to find solutions for healthier hearts.
    Ethn Dis; 2005; 15(4):804-5. PubMed ID: 16261690
    [No Abstract]   [Full Text] [Related]  

  • 53. Association of β1 and β3 adrenergic receptors gene polymorphisms with insulin resistance and high lipid profiles related to type 2 diabetes and metabolic syndrome.
    Burguete-Garcia AI; Martinez-Nava GA; Valladares-Salgado A; Bermudez Morales VH; Estrada-Velasco B; Wacher N; Peralta-Romero J; Garcia-Mena J; Parra E; Cruz M
    Nutr Hosp; 2014 Jun; 29(6):1327-34. PubMed ID: 24972470
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Relation of ADRB1, CYP2D6, and UGT1A1 polymorphisms with dose of, and response to, carvedilol or metoprolol therapy in patients with chronic heart failure.
    Baudhuin LM; Miller WL; Train L; Bryant S; Hartman KA; Phelps M; Larock M; Jaffe AS
    Am J Cardiol; 2010 Aug; 106(3):402-8. PubMed ID: 20643254
    [TBL] [Abstract][Full Text] [Related]  

  • 55. GRK5 Gln41Leu polymorphism is not associated with sensitivity to beta(1)-adrenergic blockade in humans.
    Kurnik D; Cunningham AJ; Sofowora GG; Kohli U; Li C; Friedman EA; Muszkat M; Menon UB; Wood AJ; Stein CM
    Pharmacogenomics; 2009 Oct; 10(10):1581-7. PubMed ID: 19842931
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The common Arg389gly ADRB1 polymorphism affects heart rate response to the ultra-short-acting β(1) adrenergic receptor antagonist esmolol in healthy individuals.
    Muszkat M; Hoofien A; Orlanski-Meyer E; Makhoul H; Porat E; Davidson EM; Blotnick S; Caraco Y
    Pharmacogenet Genomics; 2013 Jan; 23(1):25-8. PubMed ID: 23114278
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Association of CYP2D6 and ADRB1 genes with hypotensive and antichronotropic action of betaxolol in patients with arterial hypertension.
    Zateyshchikov DA; Minushkina LO; Brovkin AN; Savel'eva EG; Zateyshchikova AA; Manchaeva BB; Nikitin AG; Sidorenko BA; Nosikov VV
    Fundam Clin Pharmacol; 2007 Aug; 21(4):437-43. PubMed ID: 17635183
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Polymorphisms of adrenoceptors are not associated with an increased risk of adverse event in heart failure: a MERIT-HF substudy.
    Savva J; Maqbool A; White HL; Galloway SL; Yuldasheva NY; Ball SG; West RM; De Boer RA; Van Veldhuisen DJ; Balmforth AJ;
    J Card Fail; 2009 Jun; 15(5):435-41. PubMed ID: 19477404
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of common polymorphisms in the alpha1A-, alpha2B-, beta1- and beta2-adrenoreceptors on haemodynamic responses to adrenaline.
    Snapir A; Koskenvuo J; Toikka J; Orho-Melander M; Hinkka S; Saraste M; Hartiala J; Scheinin M
    Clin Sci (Lond); 2003 May; 104(5):509-20. PubMed ID: 12519093
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Adrenergic receptor polymorphisms associated with resting heart rate: the HyperGEN Study.
    Wilk JB; Myers RH; Pankow JS; Hunt SC; Leppert MF; Freedman BI; Province MA; Ellison RC
    Ann Hum Genet; 2006 Sep; 70(Pt 5):566-73. PubMed ID: 16907703
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.